Abbott | ABT - Operating Profit

Stock Price
114.85
Daily Change
0.27 0.24%
Monthly
5.59%
Yearly
-15.53%
Q1 Forecast
108.73

Abbott reported $2.25B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Agilent USD 443M 66M Sep/2025
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Danaher USD 1.5B 348M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Hologic USD 237M 16M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
Solventum Corp USD 1.69B 1.47B Sep/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD -408.9M 586.38M Sep/2025
Terumo JPY 43.88B 1.21B Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025